Sublingual capnometry tracks microcirculatory changes in septic patients.

Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med (2014) 3.37

Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med (2008) 1.61

Can venous-to-arterial carbon dioxide differences reflect microcirculatory alterations in patients with septic shock? Intensive Care Med (2015) 1.59

Endothelial and Microcirculatory Function and Dysfunction in Sepsis. Clin Chest Med (2016) 1.42

Microvascular flow and tissue oxygenation after major abdominal surgery: association with post-operative complications. Intensive Care Med (2008) 1.26

Mechanisms of critical illness--classifying microcirculatory flow abnormalities in distributive shock. Crit Care (2006) 1.21

Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence (2013) 1.16

Persistently high venous-to-arterial carbon dioxide differences during early resuscitation are associated with poor outcomes in septic shock. Crit Care (2013) 1.09

Towards integrative physiological monitoring of the critically ill: from cardiovascular to microcirculatory and cellular function monitoring at the bedside. Crit Care (2013) 0.95

Monitoring the microcirculation. J Clin Monit Comput (2012) 0.90

Deeper penetration of erythrocytes into the endothelial glycocalyx is associated with impaired microvascular perfusion. PLoS One (2014) 0.84

Bedside sublingual video imaging of microcirculation in assessing bacterial infection in cirrhosis. Dig Dis Sci (2009) 0.84

Vasospasm in cerebral inflammation. Int J Inflam (2014) 0.84

The microcirculation of the critically ill pediatric patient. Crit Care (2011) 0.80

Physiopathology of shock. J Emerg Trauma Shock (2011) 0.80

Monitoring in the intensive care. Crit Care Res Pract (2012) 0.79

Clinical pathology of the shock syndromes. J Emerg Trauma Shock (2011) 0.79

Hemodynamic management of cardiovascular failure by using PCO(2) venous-arterial difference. J Clin Monit Comput (2012) 0.79

Go with the flow--recruit the microcirculation! Intensive Care Med (2006) 0.78

A Newly Developed Sublingual Tonometric Method for the Evaluation of Tissue Perfusion and Its Validation In Vitro and in Healthy Persons In Vivo and the Results of the Measurements in COPD Patients. Crit Care Res Pract (2014) 0.77

Use of venous-to-arterial carbon dioxide tension difference to guide resuscitation therapy in septic shock. World J Crit Care Med (2016) 0.76

Early hemodynamic resuscitation in septic shock: understanding and modifying oxygen delivery. Crit Care (2014) 0.75

Monitoring Microcirculatory Blood Flow with a New Sublingual Tonometer in a Porcine Model of Hemorrhagic Shock. Biomed Res Int (2015) 0.75

Comment on "Sublingual capnometry tracks microcirculatory changes in septic patients" by Creteur et al. Intensive Care Med (2006) 0.75

Evaluation of multiple modes of oximetry monitoring as an index of splanchnic blood flow in a newborn lamb model of hypoxic, ischemic, and hemorrhagic stress. Shock (2013) 0.75

Monitoring Microcirculatory Blood Flow during Cardiopulmonary Bypass in Paediatric Cardiac Surgery Patients as a Predictor for Anaerobic Metabolism. J Clin Diagn Res (2017) 0.75

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 24.47

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37

Sepsis in European intensive care units: results of the SOAP study. Crit Care Med (2006) 11.78

International study of the prevalence and outcomes of infection in intensive care units. JAMA (2009) 11.57

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med (2003) 10.39

Mortality after surgery in Europe: a 7 day cohort study. Lancet (2012) 9.96

Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med (2010) 8.58

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33

Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med (2004) 5.90

Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery--a prospective sequential analysis*. Crit Care Med (2013) 5.88

Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med (2002) 5.84

Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA (2010) 5.80

Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial. Anesthesiology (2015) 5.52

Circulatory shock. N Engl J Med (2013) 4.95

Sepsis biomarkers: a review. Crit Care (2010) 4.76

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med (2004) 4.56

Are blood transfusions associated with greater mortality rates? Results of the Sepsis Occurrence in Acutely Ill Patients study. Anesthesiology (2008) 4.43

A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care (2008) 4.31

Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis (2012) 4.07

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med (2003) 4.04

Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med (2005) 3.97

Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care (2013) 3.90

Pulse pressure variations to predict fluid responsiveness: influence of tidal volume. Intensive Care Med (2005) 3.81

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA (2013) 3.78

Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care (2013) 3.65

High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury. Chest (2005) 3.58

The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med (2006) 3.53

Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med (2014) 3.37

Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med (2011) 3.34

Fluid challenges in intensive care: the FENICE study: A global inception cohort study. Intensive Care Med (2015) 3.27

The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med (2012) 3.18

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med (2003) 3.18

The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*. Crit Care Med (2014) 3.17

Management of bleeding following major trauma: an updated European guideline. Crit Care (2010) 3.09

Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med (2007) 3.06

C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest (2003) 2.95

Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest (2008) 2.90

Let us use the pulmonary artery catheter correctly and only when we need it. Crit Care Med (2005) 2.83

Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma (2010) 2.82

Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. Am J Respir Crit Care Med (2014) 2.78

Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study. Crit Care Med (2006) 2.74

Do all nonsurvivors of cardiogenic shock die with a low cardiac index? Chest (2003) 2.73

Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med (2005) 2.73

Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome. Crit Care Med (2013) 2.72

Evaluation of sublingual and gut mucosal microcirculation in sepsis: a quantitative analysis. Crit Care Med (2009) 2.68

Abandon the mouse research ship? Not just yet! Shock (2014) 2.60

Year in review in Intensive Care Medicine 2011: III. ARDS and ECMO, weaning, mechanical ventilation, noninvasive ventilation, pediatrics and miscellanea. Intensive Care Med (2012) 2.52

Sources of variability on the estimate of treatment effect in the PROWESS trial: implications for the design and conduct of future studies in severe sepsis. Crit Care Med (2004) 2.48

Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med (2006) 2.47

Management of bleeding following major trauma: a European guideline. Crit Care (2007) 2.40

Ethics and end-of-life care for adults in the intensive care unit. Lancet (2010) 2.40

Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often? Crit Care Med (2012) 2.39

Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med (2004) 2.33

Severe sepsis in cirrhosis. Hepatology (2009) 2.33

A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med (2010) 2.31

Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Crit Care Med (2011) 2.30

Obesity is associated with increased morbidity but not mortality in critically ill patients. Intensive Care Med (2008) 2.27

The prognostic value of muscle StO2 in septic patients. Intensive Care Med (2007) 2.25

Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med (2003) 2.23

Gamma-globulin levels in patients with community-acquired septic shock. Shock (2009) 2.21

Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis (2004) 2.17

A large-bolus injection, but not continuous infusion of sodium selenite improves outcome in peritonitis. Shock (2009) 2.17

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care (2010) 2.11

A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock (2014) 2.11

Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis. Crit Care Med (2010) 2.11

Association between duration of storage of transfused red blood cells and morbidity and mortality in adult patients: myth or reality? Transfusion (2009) 2.11

Randomized, controlled clinical trials in sepsis: has methodological quality improved over time? Crit Care Med (2002) 2.10

The Surviving Sepsis Campaign: raising awareness to reduce mortality. Crit Care (2003) 2.07

Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*. Crit Care Med (2012) 2.06

Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Med (2010) 2.05

Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial. Intensive Care Med (2003) 2.05

Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med (2003) 2.01

An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence In Acutely Ill Patients (SOAP) study. Intensive Care Med (2006) 2.00

Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail? Crit Care Med (2008) 2.00

Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis. Crit Care Med (2003) 1.98

A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock (2005) 1.97

Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Crit Care (2011) 1.91